Zobrazeno 21 - 30
of 93
pro vyhledávání: '"35"'
Autor:
Lehtinen, Tuomas, Söderlund-Strand, Anna, Petäjä, Tiina, Eriksson, Tiina, Jokiranta, Sakari, Natunen, Kari, Dillner, Joakim, Lehtinen, Matti
Publikováno v:
The Journal of Infectious Diseases, 2017 Oct . 216(8), 966-968.
Externí odkaz:
https://www.jstor.org/stable/26491637
Autor:
Jordan W. Tappero, Emmanuel Arinaitwe, Melissa D. Conrad, Norbert P. LeClair, Abel Kakuru, Philip J. Rosenthal, Humphrey Wanzira, Victor Bigira, Mary K. Muhindo, Moses R. Kamya, Bryan Greenhouse, Grant Dorsey
Publikováno v:
The Journal of infectious diseases, vol 210, iss 3
(See the editorial commentary by Taylor and Juliano on pages 335–7.) Artemisinin-based combination therapies (ACTs) have shown excellent efficacy and are now recommended to treat falciparum malaria in nearly all countries [1]. ACTs include potent,
Autor:
Ian Njeru, Daniel Langat, David Mwangi, Julia Tonui, Mercy Njeru, David Mutonga, Zephania Irura, Ahmed Abade, Melissa Dahlke
Publikováno v:
The Journal of Infectious Diseases. 208:S55-S61
BACKGROUND Kenya has experienced multiple cholera outbreaks since 1971. Cholera remains an issue of major public health importance and one of the 35 priority diseases under Kenya's updated Integrated Disease Surveillance and Response strategy. METHOD
Autor:
Andrew N. Phillips, Stefan Esser, Edward M. Gardner, Sharon B. Mannheimer, Alan R. Lifson, Edward E. Telzak, Jemma L O'Connor
Publikováno v:
The Journal of Infectious Diseases. 208:40-49
Background. We assessed factors associated with antiretroviral therapy (ART) adherence, including specific ART medications. Methods. The Strategies for Management of Antiretroviral Therapy study was an international antiretroviral therapy (ART) strat
Autor:
Milena Saqui-Salces, Mangalakumari Jeyanathan, Mauricio Castañón-Arreola, Jorge Barrios-Payán, Graham A. W. Rook, Rogelio Hernández-Pando, Avissai Alcántara-Vazquez
Publikováno v:
The Journal of Infectious Diseases. 206:1194-1205
Background. One-third of the world’s population has latent infection with Mycobacterium tuberculosis, and 10%–15% of cases of reactivation occur at extrapulmonary sites without active pulmonary tuberculosis. Methods. To establish the frequency an
Autor:
Carlos Becerril, Lisa Huang, Daniel R. Kuritzkes, Nina Lin, Ronald J. Bosch, Christine D. Palmer, Marisol Romero-Tejeda, Eileen P. Scully, Ainsley Lockhart, Mary Albrecht, Marcus Altfeld, Yvonne P. Robles
Publikováno v:
The Journal of infectious diseases. 213(5)
The aging of the human immunodeficiency virus type 1 (HIV-1)-infected population obligates a focus on the interaction between aging, comorbid conditions, and HIV-1. We recruited a cohort of HIV-1-infected men aged ≤ 35 years or ≥ 50 years who wer
Autor:
Lisa Lott, Arjun Srinivasan, Xiaoyan Lu, Philip L. Gould, Marc-Alain Widdowson, Larry J. Anderson, Fernanda C. Lessa, Michel Bunning, Dean D. Erdman, Vincent C. Marconi, Neil Pascoe
Publikováno v:
The Journal of Infectious Diseases. 200:1759-1765
BACKGROUND Adenoviruses can cause outbreaks of febrile respiratory illness in military trainees, but until 2007, adenovirus serotype 14 (Ad14) was never associated with such outbreaks. From April through June 2007, 15 trainees at one base were hospit
Autor:
Colin P. Sharp, Alice Lail, Eric Delwart, Peter Simmonds, Edward D. Gomperts, Paul Klenerman, Ruth Simmons, Clifford Leen, Sharyne M. Donfield
Publikováno v:
The Journal of Infectious Diseases. 200:1119-1125
BACKGROUND: PARV4 is a human parvovirus that was first detected in and cloned from an individual with a human immunodeficiency virus (HIV) seroconversion-like illness and that subsequently persisted in the lymphoid tissue and bone marrow. In contrast
Autor:
Selvakumar Subbian, Jeffrey D. Cirillo, Suat L. G. Cirillo, Manirath Khounlotham, Roger Smith
Publikováno v:
The Journal of Infectious Diseases. 199:1797-1806
Mycobacterium tuberculosis is one of the most important human pathogens, causing nearly 2 million deaths and 9 million new infections annually [1–4]. Cell-mediated immunity constitutes a major component of the protective immune response against M.
Publikováno v:
The Journal of infectious diseases. 158(4)
We analyzed 67 adenovirus isolates from 48 patients with AIDS. The isolates included 5 of subgenus A (all Ad31), 23 of subgenus B, 4 of subgenus C (all Ad5), and 35 of subgenus D. The subgenus A and C strains were from liver, lung, blood, urine, and